Did the COVID-19 pandemic affect short-term cancer survival rates?

Yes, a study found that cancer patients diagnosed in 2020 and 2021 had worse short-term survival compared to those diagnosed between 2015 and 2019.

What caused the decline in short-term cancer survival during the pandemic?

Researchers believe disruptions to the healthcare system, including postponed screenings and changes in access to care, were key contributors to the worse survival rates.

Which cancer types showed the most significant drops in survival during the pandemic?

Colorectal, prostate, and pancreatic cancers showed particularly large differences in one-year survival rates for patients diagnosed during the pandemic years.

Home / Health / COVID's Hidden Toll: Worsened Cancer Survival

COVID's Hidden Toll: Worsened Cancer Survival

5 Feb

•

Summary

Cancer patients diagnosed during 2020-2021 had worse short-term survival.
Disruptions to healthcare likely contributed to worse outcomes.
Colorectal, prostate, and pancreatic cancers showed significant survival drops.

COVID's Hidden Toll: Worsened Cancer Survival

A new study indicates that disruptions to cancer diagnosis and treatment during the COVID-19 pandemic have negatively impacted patient survival. Researchers found that individuals diagnosed with cancer in 2020 and 2021 exhibited lower short-term survival rates compared to those diagnosed in the pre-pandemic years of 2015-2019. This trend was consistent across multiple cancer types and stages.

While COVID-19 itself posed risks to cancer patients, the study aimed to isolate the effects of systemic disruptions. Experts suggest that postponed screenings and altered healthcare access played a significant role in these poorer outcomes. The findings highlight the vulnerability of cancer care to public health crises.